Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations — Neurological signs and symptoms

Molecular Genetics and Metabolism

Volumn 122, Issue , 2017, Pages 1-7

  Shapiro, Elsa G ^a,b   Jones, Simon A ^c   Escolar, Maria L ^d  

^a Shapiro Neuropsychology Consultants   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Cognition disorders; Lysosomal storage diseases; Mucopolysaccharidoses; Neurobehavioral manifestations

Indexed keywords

BRAIN DEVELOPMENT; BRAIN DISEASE; CLINICAL FEATURE; COGNITION; DISEASE COURSE; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; MUCOPOLYSACCHARIDOSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROBLEM BEHAVIOR; REVIEW; SANFILIPPO SYNDROME; BRAIN; CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT; COGNITIVE DEFECT; CYTOLOGY; DISEASE EXACERBATION; DRUG EFFECT; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYSOSOME; METABOLISM; NEUROPSYCHOLOGICAL TEST; ORGANIZATION; PATHOLOGY; PRESCHOOL CHILD;

GLYCOSAMINOGLYCAN; MELATONIN;

BRAIN; CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITIVE DYSFUNCTION; CONGRESSES AS TOPIC; DISEASE PROGRESSION; GLYCOSAMINOGLYCANS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYSOSOMES; MELATONIN; MUCOPOLYSACCHARIDOSES; NEUROPSYCHOLOGICAL TESTS;

EID: 85032204822     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2017.08.009     Document Type: Review

References (76)

1. Neufeld, E.F., Muenzer, J., The mucopolysaccharidoses. Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., (eds.) The Metabolic and Molecular Bases of Inherited Disease, 2001, McGraw-Hill Medical Publishing Division, New York, 3421–3452.
2. Muenzer, J., Overview of the mucopolysaccharidoses. Rheumatology (Oxford) 50:Suppl. 5 (2011), v4–v12.
3. Bax, M.C.O., Colville, G.A., Behaviour in mucopolysaccharide disorders. Arch. Dis. Child. 73 (1995), 77–81.
4. Węgrzyn, G., Jakóbkiewicz-Banecka, J., Narajczyk, M., Wiśniewski, A., Piotrowska, E., Gabig-Cimińska, M., Kloska, A., Słomińska-Wojewódzka, M., Korzon-Burakowska, A., Węgrzyn, A., Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?. Med. Hypotheses 75 (2010), 605–609.
5. Shapiro, E.G., Lockman, L.A., Balthazor, M., Krivit, W., Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J. Inherit. Metab. Dis. 18 (1995), 413–429.
6. Buhrman, D., Thakkar, K., Poe, M., Escolar, M.L., Natural history of Sanfilippo syndrome type A. J. Inherit. Metab. Dis. 37 (2014), 431–437.
7. Héron, B., Mikaeloff, Y., Froissart, R., Caridade, G., Maire, I., Caillaud, C., Levade, T., Chabrol, B., Feillet, F., Ogier, H., Valayannopoulos, V., Michelakakis, H., Zafeiriou, D., Lavery, L., Wraith, E., Danos, O., Heard, J.M., Tardieu, M., Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am. J. Med. Genet. A 155A (2011), 58–68.
8. Gilkes, J.A., Heldermon, C.D., Mucopolysaccharidosis III (Sanfilippo Syndrome) — disease presentation and experimental therapies. Pediatr. Endocrinol. Rev. 12:Suppl. 1 (2014), 133–140.
9. Rumsey, R.K., Rudser, K., Delaney, K., Potegal, M., Whitley, C.B., Shapiro, E., Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA. J. Pediatr. 164 (2014), 1147–1151 (e1141).
10. Shapiro, E., King, K., Ahmed, A., Rudser, K., Rumsey, R., Yund, B., Delaney, K., Nestrasil, I., Whitley, C., Potegal, M., The neurobehavioral phenotype in mucopolysaccharidosis type IIIB: an exploratory study. Mol. Genet. Metab. Rep. 6 (2016), 41–47.
11. Wallace, S.P., Prutting, C.A., Gerber, S.E., Degeneration of speech, language, and hearing in a patient with mucopolysaccharidosis VII. Int. J. Pediatr. Otorhinolaryngol. 19 (1990), 97–107.
12. Johnson, B.A., Dajnoki, A., Bodamer, O.A., Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I, Curr Protoc. Hum. Genet. 84 (2015), 1–8.
13. Beck, M., Arn, P., Giugliani, R., Muenzer, J., Okuyama, T., Taylor, J., Fallet, S., The natural history of MPS I: global perspectives from the MPS I Registry. Genet. Med. 16 (2014), 759–765.
14. Cleary, M.A., Wraith, J.E., The presenting features of mucopolysaccharidosis type IH (Hurler syndrome). Acta Paediatr. 84 (1995), 337–339.
15. Shapiro, E.G., Nestrasil, I., Rudser, K., Delaney, K., Kovac, V., Ahmed, A., Yund, B., Orchard, P.J., Eisengart, J., Niklason, G.R., Raiman, J., Mamak, E., Cowan, M.J., Bailey-Olson, M., Harmatz, P., Shankar, S.P., Cagle, S., Ali, N., Steiner, R.D., Wozniak, J., Lim, K.O., Whitley, C.B., Neurocognition across the spectrum of mucopolysaccharidosis type I: age, severity, and treatment. Mol. Genet. Metab. 116 (2015), 61–68.
16. Scarpa, M., Orchard, P.J., Schulz, A., Dickson, P.I., Haskins, M.E., Escolar, M.L., Giugliani, R., Treatment of brain disease in mucopolysaccharidoses. Mol. Genet. Metab. 122 (2017), 24–34.
17. Aldenhoven, M., Boelens, J.J., de Koning, T.J., The clinical outcome of Hurler syndrome after stem cell transplantation. Biol. Blood Marrow Transplant. 14 (2008), 485–498.
18. Peters, C., Shapiro, E.G., Anderson, J., Henslee-Downey, P.J., Klemperer, M.R., Cowan, M.J., Saunders, E.F., de Alarcon, P.A., Twist, C., Nachman, J.B., Hale, G.A., Harris, R.E., Rozans, M.K., Kurtzberg, J., Grayson, G.H., Williams, T.E., Lenarsky, C., Wagner, J.E., Krivit, W., The Storage Disease Collaborative Study Group. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 91 (1998), 2601–2608.
19. Vellodi, A., Young, E.P., Cooper, A., Wraith, J.E., Winchester, B., Meaney, C., Ramaswami, U., Will, A., Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch. Dis. Child. 76 (1997), 92–99.
20. Souillet, G., Guffon, N., Maire, I., Pujol, M., Taylor, P., Sevin, F., Bleyzac, N., Mulier, C., Durin, A., Kebaili, K., Galambrun, C., Bertrand, Y., Froissart, R., Dorche, C., Gebuhrer, L., Garin, C., Berard, J., Guibaud, P., Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant. 31 (2003), 1105–1117.
21. Lücke, T., Das, A.M., Hartmann, H., Sykora, K.W., Donnerstag, F., Schmid-Ott, G., Grigull, L., Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study. Dev. Med. Child Neurol. 49 (2007), 693–696.
22. Whitley, C.B., Belani, K.G., Chang, P.N., Summers, C.G., Blazar, B.R., Tsai, M.Y., Latchaw, R.E., Ramsay, N.K.C., Kersey, J.H., Long-term outcome of Hurler syndrome following bone marrow transplantation. Am. J. Med. Genet. 46 (1993), 209–218.
23. Coletti, H.Y., Aldenhoven, M., Yelin, K., Poe, M.D., Kurtzberg, J., Escolar, M.L., Long-term functional outcomes of children with Hurler syndrome treated with unrelated umbilical cord blood transplantation. JIMD Rep. 20 (2015), 77–86.
24. Aldenhoven, M., Wynn, R.F., Orchard, P.J., O'Meara, A., Veys, P., Fischer, A., Valayannopoulos, V., Neven, B., Rovelli, A., Prasad, V.K., Tolar, J., Allewelt, H., Jones, S.A., Parini, R., Renard, M., Bordon, V., Wulffraat, N.M., de Koning, T.J., Shapiro, E.G., Kurtzberg, J., Boelens, J.J., Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood 125 (2015), 2164–2172.
25. Staba, S.L., Escolar, M.L., Poe, M., Kim, Y., Martin, P.L., Szabolcs, P., Allison-Thacker, J., Wood, S., Wenger, D.A., Rubinstein, P., Hopwood, J.J., Krivit, W., Kurtzberg, J., Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N. Engl. J. Med. 350 (2004), 1960–1969.
26. Zafeiriou, D.I., Batzios, S.P., Brain and spinal MR imaging findings in mucopolysaccharidoses: a review. Am. J. Neuroradiol. 34 (2013), 5–13.
27. Vedolin, L., Schwartz, I.V.D., Komlos, M., Schuch, A., Azevedo, A.C., Vieira, T., Maeda, F.K., Marques da Silva, A.M., Giugliani, R., Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology 69 (2007), 917–924.
28. Seto, T., Kono, K., Morimoto, K., Inoue, Y., Shintaku, H., Hattori, H., Matsuoka, O., Yamano, T., Tanaka, A., Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann. Neurol. 50 (2001), 79–92.
29. Matheus, M.G., Castillo, M., Smith, J.K., Armao, D., Towle, D., Muenzer, J., Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 46 (2004), 666–672.
30. Wraith, J.E., The mucopolysaccharidoses: a clinical review and guide to management. Arch. Dis. Child. 72 (1995), 263–267.
31. Muenzer, J., Wraith, J.E., Clarke, L.A., Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 123 (2009), 19–29.
32. Kiely, B.T., Kohler, J.L., Coletti, H.Y., Poe, M.D., Escolar, M.L., Early disease progression of Hurler syndrome. Orphanet. J. Rare Dis., 12, 2017, 32.
33. Bjoraker, K.J., Delaney, K., Peters, C., Krivit, W., Shapiro, E.G., Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation. J. Dev. Behav. Pediatr. 27 (2006), 290–296.
34. Dusing, S.C., Thorpe, D., Rosenberg, A., Mercer, V., Escolar, M.L., Gross motor abilities in children with Hurler syndrome. Dev. Med. Child Neurol. 48 (2006), 927–930.
35. Kiely, B.T., Poe, M.D., Escolar, M.L., Natural history of Hurler syndrome. Mol. Genet. Metab., 117, 2016, S67.
36. White, K., Kim, T., Neufeld, J.A., Clinical assessment and treatment of carpal tunnel syndrome in the mucopolysaccharidoses. J. Pediatr. Rehabil. Med. 3 (2010), 57–62.
37. White, K.K., Harmatz, P., Orthopedic management of mucopolysaccharide disease. J. Pediatr. Rehabil. Med. 3 (2010), 47–56.
38. Ahmed, A., Whitley, C.B., Cooksley, R., Rudser, K., Cagle, S., Ali, N., Delaney, K., Yund, B., Shapiro, E., Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the alpha-L-iduronidase gene in Hurler-Scheie syndrome. Mol. Genet. Metab. 111 (2014), 123–127.
39. King, K., Shapiro, E., Rudser, K., Whitley, C.B., Emotional-behavioral functioning in individuals with MPS I: a longitudinal approach. Mol. Genet. Metab. Rep. 117 (2016), S14–124.
40. Potegal, M., Yund, B., Rudser, K., Ahmed, A., Delaney, K., Nestrasil, I., Whitley, C.B., Shapiro, E.G., Mucopolysaccharidosis Type IIIA presents as a variant of Klüver-Bucy syndrome. J. Clin. Exp. Neuropsychol. 35 (2013), 608–616.
41. Shapiro, E., Guler, O.E., Rudser, K., Delaney, K., Bjoraker, K., Whitley, C., Tolar, J., Orchard, P., Provenzale, J., Thomas, K., An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT). Mol. Genet. Metab. 107 (2012), 116–121.
42. Holt, J.B., Poe, M.D., Escolar, M.L., Natural progression of neurological disease in mucopolysaccharidosis type II. Pediatrics 127 (2011), e1258–1265.
43. Martin, R., Beck, M., Eng, C., Giugliani, R., Harmatz, P., Muñoz, V., Muenzer, J., Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 121 (2008), e377–e386.
44. Wraith, J.E., Scarpa, M., Beck, M., Bodamer, O.A., De, M.L., Guffon, N., Meldgaard, L.A., Malm, G., Van der Ploeg, A.T., Zeman, J., Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur. J. Pediatr. 167 (2008), 267–277.
45. Yund, B., Rudser, K., Ahmed, A., Kovac, V., Nestrasil, I., Raiman, J., Mamak, E., Harmatz, P., Steiner, R., Lau, H., Vekaria, P., Wozniak, J.R., Lim, K.O., Delaney, K., Whitley, C., Shapiro, E.G., Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II. Mol. Genet. Metab. 114 (2015), 170–177.
46. Shapiro, E.G., Rudser, K., Ahmed, A., Steiner, R.D., Delaney, K.A., Yund, B., King, K., Kunin-Batson, A., Eisengart, J., Whitley, C.B., A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II. Mol. Genet. Metab. Rep. 7 (2016), 32–39.
47. Wraith, J.E., Beck, M., Giugliani, R., Clarke, J., Martin, R., Muenzer, J., Initial report from the Hunter Outcome Survey. Genet. Med. 10 (2008), 508–516.
48. Escolar, M., Jardim, L., Muenzer, J., Morin, I., Scarpa, M., Neurologic involvement in Hunter syndrome: data from the Hunter Outcome Survey (HOS). Mol. Genet. Metab., 108, 2013, S38.
49. Holt, J., Poe, M.D., Escolar, M.L., Early clinical markers of central nervous system involvement in mucopolysaccharidosis type II. J. Pediatr. 159 (2011), 320–326.
50. Young, I.D., Harper, P.S., The natural history of the severe form of Hunter's syndrome: a study based on 52 cases. Dev. Med. Child Neurol. 25 (1983), 481–489.
51. Schwartz, I.V.D., Ribeiro, M.G., Mota, J.G., Toralles, M.B.P., Correia, P., Horovitz, D., Santos, E.S., Monlleo, I.L., Fett-Conte, A.C., Sobrinho, R.P.O., Norato, D.Y.J., Paula, A.C., Kim, C.A., Duarte, A.R., Boy, R., Valadares, E., De Michelena, M., Mabe, P., Martinhago, C.D., Pina-Neto, J.M., Kok, F., Leistner-Segal, S., Burin, M.G., Giugliani, R., A clinical study of 77 patients with mucopolysaccharidosis type II. Acta Paediatr. Suppl. 96 (2007), 63–70.
52. Cho, Y.S., Kim, J.H., Kim, T.W., Chung, S.C., Chang, S.A., Jin, D.K., Otologic manifestations of Hunter syndrome and their relationship with speech development. Audiol. Neurootol. 13 (2008), 206–212.
53. Bonanni, P., Volzone, A., Randazzo, G., Antoniazzi, L., Rampazzo, A., Scarpa, M., Nobili, L., Nocturnal frontal lobe epilepsy in mucopolysaccharidosis. Brain Dev. 36 (2014), 826–829.
54. Valstar, M.J., Neijs, S., Bruggenwirth, H.T., Olmer, R., Ruijter, G.J.G., Wevers, R.A., van Diggelen, O.P., Poorthuis, B.J., Halley, D.J., Wijburg, F.A., Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations. Ann. Neurol. 68 (2010), 876–887.
55. Valstar, M.J., Bruggenwirth, H.T., Olmer, R., Wevers, R.A., Verheijen, F.W., Poorthuis, B.J., Halley, D.J., Wijburg, F.A., Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. J. Inherit. Metab. Dis. 33 (2010), 759–767.
56. Ruijter, G.J.G., Valstar, M.J., van de Kamp, J.M., van der Helm, R.M., Durand, S., van Diggelen, O.P., Wevers, R.A., Poorthuis, B.J., Pshezhetsky, A.V., Wijburg, F.A., Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands. Mol. Genet. Metab. 93 (2008), 104–111.
57. Shapiro, E.G., Nestrasil, I., Delaney, K.A., Rudser, K., Kovac, V., Nair, N., Richard, C.W. III, Haslett, P., Whitley, C.B., A prospective natural history study of mucopolysaccharidosis type IIIA. J. Pediatr. 170 (2016), 278–287.
58. Lee, C., Dineen, T.E., Brack, M., Kirsch, J.E., Runge, V.M., The mucopolysaccharidoses: characterization by cranial MR imaging. Am. J. Neuroradiol. 14 (1993), 1285–1292.
59. Valstar, M.J., Marchal, J.P., Grootenhuis, M., Colland, V., Wijburg, F.A., Cognitive development in patients with mucopolysaccharidosis type III (Sanfilippo syndrome). Orphanet. J. Rare Dis., 6, 2011, 43.
60. Moog, U., van Mierlo, I., van Schrojenstein Lantman-de Valk, H.M.J., Spaapen, L., Maaskant, M.A., Curfs, L.M.G., Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems?. Am. J. Med. Genet. C Semin. Med. Genet. 145C (2007), 293–301.
61. Fraser, J., Gason, A.A., Wraith, J.E., Delatycki, M.B., Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study. Arch. Dis. Child. 90 (2005), 1239–1242.
62. Muenzer, J., Beck, M., Eng, C.M., Escolar, M.L., Giugliani, R., Guffon, N.H., Harmatz, P., Kamin, W., Kampmann, C., Koseoglu, S.T., Link, B., Martin, R.A., Molter, D.W., Muñoz Rojas, M.V., Ogilvie, J.W., Parini, R., Ramaswami, U., Scarpa, M., Schwartz, I.V., Wood, R.E., Wraith, E., Multidisciplinary management of Hunter syndrome. Pediatrics 124 (2009), e1228–e1239.
63. Young, I.D., Harper, P.S., Psychosocial problems in Hunter's syndrome. Child Care Health Dev. 7 (1981), 201–209.
64. Shapiro, E.G., Nestrasil, I., Ahmed, A., Wey, A., Rudser, K., Delaney, K., Rumsey, R., Haslett, P., Whitley, C.B., Potegal, M., Quantifying behaviors of children with Sanfilippo syndrome: the Sanfilippo behavior rating scale. Mol. Genet. Metab. 114 (2015), 594–598.
65. Mahon, L.V., Lomax, M., Grant, S., Cross, E., Hare, D.J., Wraith, J.E., Jones, S., Bigger, B., Langford-Smith, K., Canal, M., Assessment of sleep in children with mucopolysaccharidosis type III. PLoS One, 9, 2014, e84128.
66. Guerrero, J.M., Pozo, D., Diaz-Rodriguez, J.L., Martinez-Cruz, F., Vela-Campos, F., Impairment of the melatonin rhythm in children with Sanfilippo syndrome. J. Pineal. Res. 40 (2006), 192–193.
67. Mumford, R.A., Mahon, L.V., Jones, S., Bigger, B., Canal, M., Hare, D.J., Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome). J. Neurodev. Disord., 7, 2015, 31.
68. Fraser, J., Wraith, J.E., Delatycki, M.B., Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians. Clin. Genet. 62 (2002), 418–421.
69. Cross, E.M., Hare, D.J., Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders. J. Inherit. Metab. Dis. 36 (2013), 189–200.
70. Malcolm, C., Hain, R., Gibson, F., Adams, S., Anderson, G., Forbat, L., Challenging symptoms in children with rare life-limiting conditions: findings from a prospective diary and interview study with families. Acta. Paediatr. 101 (2012), 985–992.
71. Roberts, J., Stewart, C., Kearney, S., Management of the behavioural manifestations of Hunter syndrome. Br. J. Nurs., 25, 2016 22, 24, 26–30.
72. Poe, M.D., Chagnon, S.L., Escolar, M.L., Early treatment is associated with improved cognition in Hurler syndrome. Ann. Neurol. 76 (2014), 747–753.
73. Terlato, N.J., Cox, G.F., Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature. Genet. Med. 5 (2003), 286–294.
74. Shapiro, E.G., Escolar, M.L., Delaney, K.A., Mitchell, J.J., Assessments of neurocognitive and behavioral function in the mucopolysaccharidoses. Mol. Genet. Metab. 122 (2017), 8–16.
75. Vedolin, L., Schwartz, I.V.D., Komlos, M., Schuch, A., Puga, A.C., Pinto, L.L.C., Pires, A.P., Giugliani, R., Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. Am. J. Neuroradiol. 28 (2007), 1029–1033.
76. Zafeiriou, D.I., Savvopoulou-Augoustidou, P.A., Sewell, A., Papadopoulou, F., Badouraki, M., Vargiami, E., Gombakis, N.P., Katzos, G.S., Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B). Brain Dev. 23 (2001), 385–389.